E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells

Pigment Cell and Melanoma Research

Volumn 26, Issue 4, 2013, Pages 555-570

  Lobos González, Lorena ^a,b   Aguilar, Lorena ^a   Diaz, Jorge ^a   Diaz, Natalia ^a   Urra, Hery ^a   Torres, Vicente A ^c   Silva, Veronica ^b   Fitzpatrick, Christopher ^b   Lladser, Alvaro ^b   Hoek, Keith S ^d   Leyton, Lisette ^a   Quest, Andrew F G ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Fundacion Ciencia para la Vida   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CAV1; E cadherin; Melanoma model; Metastasis; Molecular switch; Tumor suppression

Indexed keywords

ACTIN; BETA CATENIN; CAVEOLIN 1; NERVE CELL ADHESION MOLECULE; RAC1 PROTEIN; UVOMORULIN;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; IN VITRO STUDY; LUNG METASTASIS; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BETA CATENIN; CADHERINS; CAVEOLIN 1; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEUROPEPTIDES; PHENOTYPE; RAC1 GTP-BINDING PROTEIN; SKIN NEOPLASMS;

MURINAE; MUS;

EID: 84879787916     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12085     Document Type: Article

References (52)

1. Ando, T., Ishiguro, H., Kimura, M., Mitsui, A., Mori, Y., Sugito, N., Tomoda, K., Mori, R., Harada, K., Katada, T., et al. (2007). The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol. Rep. 18, 601-609.
2. Augustine, C.K., Yoshimoto, Y., Gupta, M., Zipfel, P.A., Selim, M.A., Febbo, P., Pendergast, A.M., Peters, W.P., and Tyler, D.S. (2008). Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res. 68, 3777-3784.
3. Barbachano, A., Ordonez-Moran, P., Garcia, J.M., Sanchez, A., Pereira, F., Larriba, M.J., Martinez, N., Hernandez, J., Landolfi, S., Bonilla, F., et al. (2010). SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity. Oncogene 29, 4800-4813.
4. Bartz, R., Zhou, J., Hsieh, J.T., Ying, Y., Li, W., and Liu, P. (2008). Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo. Int. J. Cancer 122, 520-525.
5. Bender, F.C., Reymond, M.A., Bron, C., and Quest, A.F. (2000). Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res. 60, 5870-5878.
6. Bender, F., Montoya, M., Monardes, V., Leyton, L., and Quest, A.F. (2002). Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol. Res. 35, 151-167.
7. Capozza, F., Williams, T.M., Schubert, W., Mcclain, S., Bouzahzah, B., Sotgia, F., and Lisanti, M.P. (2003). Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am. J. Pathol. 162, 2029-2039.
8. Casazza, A., Finisguerra, V., Capparuccia, L., Camperi, A., Swiercz, J.M., Rizzolio, S., Rolny, C., Christensen, C., Bertotti, A., Sarotto, I., et al. (2010). Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J. Clin. Invest. 120, 2684-2698.
9. Chen, L., Park, S.M., Tumanov, A.V., Hau, A., Sawada, K., Feig, C., Turner, J.R., Fu, Y.X., Romero, I.L., Lengyel, E., et al. (2010). CD95 promotes tumour growth. Nature 465, 492-496.
10. Du, Z.M., Hu, C.F., Shao, Q., Huang, M.Y., Kou, C.W., Zhu, X.F., Zeng, Y.X., and Shao, J.Y. (2009). Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int. J. Cancer 125, 1832-1841.
11. Engelman, J.A., Wykoff, C.C., Yasuhara, S., Song, K.S., Okamoto, T., and Lisanti, M.P. (1997). Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272, 16374-16381.
12. Felicetti, F., Parolini, I., Bottero, L., Fecchi, K., Errico, M.C., Raggi, C., Biffoni, M., Spadaro, F., Lisanti, M.P., Sargiacomo, M., et al. (2009). Caveolin-1 tumor-promoting role in human melanoma. Int. J. Cancer 125, 1514-1522.
13. Gray-Schopfer, V.C., Cheong, S.C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z.A., Marais, R., Wynford-Thomas, D., and Bennett, D.C. (2006). Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br. J. Cancer 95, 496-505.
14. Gray-Schopfer, V., Wellbrock, C., and Marais, R. (2007). Melanoma biology and new targeted therapy. Nature 445, 851-857.
15. Hoek, K.S., and Goding, C.R. (2010). Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 23, 746-759.
16. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Dobbeling, U., Kobert, N., Schaerer, L., Hemmi, S., and Dummer, R. (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650-656.
17. Holgren, C., Dougherty, U., Edwin, F., Cerasi, D., Taylor, I., Fichera, A., Joseph, L., Bissonnette, M., and Khare, S. (2010). Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas. Oncogene 29, 5241-5253.
18. Kang, J.H., Song, K.H., Jeong, K.C., Kim, S., Choi, C., Lee, C.H., and Oh, S.H. (2011). Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells. BMC Cancer 11, 334.
19. Koleske, A.J., Baltimore, D., and Lisanti, M.P. (1995). Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. U.S.A. 92, 1381-1385.
20. Kreizenbeck, G.M., Berger, A.J., Subtil, A., Rimm, D.L., and Gould Rothberg, B.E. (2008). Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev. 17, 949-958.
21. Larue, L., and Delmas, V. (2006). The WNT/Beta-catenin pathway in melanoma. Front. Biosci. 11, 733-742.
22. Lavie, Y., Fiucci, G., and Liscovitch, M. (1998). Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273, 32380-32383.
23. Li, W.P., Liu, P., Pilcher, B.K., and Anderson, R.G. (2001). Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J. Cell Sci. 114, 1397-1408.
24. Lin, M.I., Yu, J., Murata, T., and Sessa, W.C. (2007). Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res. 67, 2849-2856.
25. Maret, D., Gruzglin, E., Sadr, M.S., Siu, V., Shan, W., Koch, A.W., Seidah, N.G., Del Maestro, R.F., and Colman, D.R. (2010). Surface expression of precursor N-cadherin promotes tumor cell invasion. Neoplasia 12, 1066-1080.
26. Margineanu, E., Cotrutz, C.E., and Cotrutz, C. (2008). Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev. Med. Chir. Soc. Med. Nat. Iasi 112, 432-436.
27. Mehrotra, S., Languino, L.R., Raskett, C.M., Mercurio, A.M., Dohi, T., and Altieri, D.C. (2010). IAP regulation of metastasis. Cancer Cell 17, 53-64.
28. Molina-Ortiz, I., Bartolome, R.A., Hernandez-Varas, P., Colo, G.P., and Teixido, J. (2009). Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA. J. Biol. Chem. 284, 15147-15157.
29. Nguyen, D.X., Bos, P.D., and Massague, J. (2009). Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274-284.
30. Nishita, M., Enomoto, M., Yamagata, K., and Minami, Y. (2010). Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells. Trends Cell Biol. 20, 346-354.
31. Podsypanina, K., Du, Y.C., Jechlinger, M., Beverly, L.J., Hambardzumyan, D., and Varmus, H. (2008). Seeding and propagation of untransformed mouse mammary cells in the lung. Science 321, 1841-1844.
32. Pouponnot, C., Sii-Felice, K., Hmitou, I., Rocques, N., Lecoin, L., Druillennec, S., Felder-Schmittbuhl, M.P., and Eychene, A. (2006). Cell context reveals a dual role for Maf in oncogenesis. Oncogene 25, 1299-1310.
33. Quest, A.F., Leyton, L., and Parraga, M. (2004). Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem. Cell Biol. 82, 129-144.
34. Quest, A.F., Gutierrez-Pajares, J.L., and Torres, V.A. (2008). Caveolin-1: an ambiguous partner in cell signalling and cancer. J. Cell Mol. Med. 12, 1130-1150.
35. Quest, A.F.G., Lobos-Gonzalez, L., Núnez, S., Sanhueza, C., Fernández, J.G., Aguirre, A., Rodríguez, D., Leyton, L., and Torres, V.A. (2013). The CAV1 connection to cell death and survival. Curr. Mol. Med. 13, 266-281.
36. Ravid, D., Chuderland, D., Landsman, L., Lavie, Y., Reich, R., and Liscovitch, M. (2008). Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Exp. Cell Res. 314, 2762-2773.
37. Rodriguez, D.A., Tapia, J.C., Fernandez, J.G., Torres, V.A., Munoz, N., Galleguillos, D., Leyton, L., and Quest, A.F. (2009). Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. Mol. Biol. Cell 20, 2297-2310.
38. Savage, K., Lambros, M.B., Robertson, D., Jones, R.L., Jones, C., Mackay, A., James, M., Hornick, J.L., Pereira, E.M., Milanezi, F., et al. (2007). Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin. Cancer Res. 13, 90-101.
39. Singh, B., Berry, J.A., Shoher, A., Ayers, G.D., Wei, C., and Lucci, A. (2007). COX-2 involvement in breast cancer metastasis to bone. Oncogene 26, 3789-3796.
40. Sun, X.H., Liu, Z.Y., Chen, H., Beardsley, A.R., Qi, Q., and Liu, J. (2009). A conserved sequence in caveolin-1 is both necessary and sufficient for caveolin polarity and cell directional migration. FEBS Lett. 583, 3681-3689.
41. Tahir, S.A., Yang, G., Goltsov, A.A., Watanabe, M., Tabata, K., Addai, J., Fattah el, M.A., Kadmon, D., and Thompson, T.C. (2008). Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer. Cancer Res. 68, 731-739.
42. Tirado, O.M., Maccarthy, C.M., Fatima, N., Villar, J., Mateo-Lozano, S., and Notario, V. (2010). Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation. Int. J. Cancer 126, 426-436.
43. Torres, V.A., Tapia, J.C., Rodriguez, D.A., Parraga, M., Lisboa, P., Montoya, M., Leyton, L., and Quest, A.F. (2006). Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J. Cell Sci. 119, 1812-1823.
44. Torres, V.A., Tapia, J.C., Rodriguez, D.A., Lladser, A., Arredondo, C., Leyton, L., and Quest, A.F. (2007). E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription. Mol. Cell. Biol. 27, 7703-7717.
45. Trimmer, C., Whitaker-Menezes, D., Bonuccelli, G., Milliman, J.N., Daumer, K.M., Aplin, A.E., Pestell, R.G., Sotgia, F., Lisanti, M.P., and Capozza, F. (2010). CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway. Cancer Res. 70, 7489-7499.
46. Urra, H., Torres, V.A., Ortiz, R.J., Lobos, L., Diaz, M.I., Diaz, N., Hartel, S., Leyton, L., and Quest, A.F. (2012). Caveolin-1-enhanced motility and focal adhesion turnover require tyrosine-14 but not accumulation to the rear in metastatic cancer cells. PLoS ONE 7, e33085.
47. Watanabe, M., Yang, G., Cao, G., Tahir, S.A., Naruishi, K., Tabata, K., Fattah, E.A., Rajagopalan, K., Timme, T.L., Park, S., et al. (2009). Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression. Mol. Cancer Res. 7, 1446-1455.
48. Wendt, M.K., Taylor, M.A., Schiemann, B.J., and Schiemann, W.P. (2011). Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol. Biol. Cell 22, 2423-2435.
49. Widmer, D.S., Cheng, P.F., Eichhoff, O.M., Belloni, B.C., Zipser, M.C., Schlegel, N.C., Javelaud, D., Mauviel, A., Dummer, R., and Hoek, K.S. (2012). Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell Melanoma Res. 25, 343-353.
50. Wiechen, K., Diatchenko, L., Agoulnik, A., Scharff, K.M., Schober, H., Arlt, K., Zhumabayeva, B., Siebert, P.D., Dietel, M., Schafer, R., et al. (2001). Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159, 1635-1643.
51. Wu, Y., Lin, Y., Liu, H., and Li, J. (2008). Inhibition of invasion and up-regulation of E-cadherin expression in human malignant melanoma cell line A375 by (-)-epigallocatechin-3-gallate. J. Huazhong Univ. Sci. Technol. Med. Sci. 28, 356-359.
52. Yang, L., Han, Y., Suarez Saiz, F., and Minden, M.D. (2007). A tumor suppressor and oncogene: the WT1 story. Leukemia 21, 868-876.